Oxadiazole inhibitors of HIPK2 for treating kidney fibrosis
US-10669266-B2 · Jun 2, 2020 · US
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 62791214 |
| Family type | — |
| Earliest priority | Jan 6, 2017 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US10669266B2 — Oxadiazole inhibitors of HIPK2 for treating kidney fibrosis |
Best representative member for this family based on priority and filing country.
US10669266B2 — Oxadiazole inhibitors of HIPK2 for treating kidney fibrosis (published Jun 2, 2020)
Related publications in this family.
US-10669266-B2 · Jun 2, 2020 · US
US-2019352292-A1 · Nov 21, 2019 · US